Detalles de la búsqueda
1.
Therapeutic cancer vaccination against mutant calreticulin in myeloproliferative neoplasms induces expansion of specific T cells in the periphery but specific T cells fail to enrich in the bone marrow.
Front Immunol
; 14: 1240678, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37662956
2.
Therapeutic Cancer Vaccination With a Peptide Derived From the Calreticulin Exon 9 Mutations Induces Strong Cellular Immune Responses in Patients With CALR-Mutant Chronic Myeloproliferative Neoplasms.
Front Oncol
; 11: 637420, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-33718228
Resultados
1 -
2
de 2
1
Próxima >
>>